ArticleAmerican journal of hematology2025

Five-Year Real-World Safety of Inotuzumab Ozogamicin Before Hematopoietic Stem Cell Transplantation in B-Cell Precursor Acute Lymphoblastic Leukemia.

Marcos de Lima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.